Onco-Innovations Ltd.

Onco-Innovations (CBOE: ONCO) is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer.

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Link to Press Release: https://t.co/CsH69cTCQd

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

Link to Press Release: https://t.co/mIHJVDH7aN

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program

Link to Press Release: https://t.co/bD8JwyzPS3

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program

Read Press Release: https://t.co/mIuy22p28y

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

Read Press Release: https://t.co/yh7RYotVNB

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

Read Press Release: https://t.co/tGawYCViV1

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Announces Initiation of Research Collaboration within PROmAI

Read Press Release: https://t.co/FDPA3rjBmE

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

Read Press Release: https://t.co/BFB4kQ5NK8

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

Read Press Release: https://t.co/Mm4BynjWxK

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

Read Press Release: https://t.co/PKZCTaibSn

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program

Read Press Release: https://t.co/S422sE9kRD

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies

Read Press Release: https://t.co/75rrPTEONc

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program

Read Press Release: https://t.co/la7kgLeJCc

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

Read Press Release: https://t.co/IRAsn8J3Kf

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy

Read Press Release: https://t.co/1WXiZbQGQx

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care

Read Press Release: https://t.co/foiggrEpmR

#CancerResearch #Biotech #AI #stockmarket

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Engages Investment Bank to Pursue #Nasdaq Cross-listing and Potential Concurrent Equity Offering

Read Press Release: https://t.co/nFrX7HjwVF

#CancerResearch #biotech #AI #Stocks

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

Read Press Release: https://t.co/1qZZ5HecTS

#CancerResearch #StockMarket #AI

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

https://t.co/17lSKOUsav

#CancerResearch #AI

[Onco-Innovations Ltd. @OncoInnovations]

Onco-Innovations’ Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment

Read Press Release: https://t.co/dgkCyF8ZF5

#AI #CancerResearch